Allegro Ophthalmics Announces Positive Results of Vehicle-controlled Ex-U.S. Phase 2 Trial of ALG-1007 for the Treatment of Dry Eye Disease
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)-- #ASCRS2021--Allegro Ophthalmics announces positive results of ex-U.S. Phase 2 trial of ALG-1007 for the treatment of dry eye disease; FDA acceptance of IND.